Mesenchymal-like OVCAR8 cells displaying resistance to cisplatin were resensitized via the inhibition of TWIST1, leading to reduced Akt activation under cell culture conditions and reduced tumor growth in vivo [31,32]. This evidence concerns the gene AKT1 and neoplasm.